Skip to Content
MIT News magazine

Cancer Tracker

Implantable device monitors tumors
August 18, 2009

Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but offer only a snapshot of the tumor at a single moment in time. Monitoring a tumor for weeks or months after the biopsy would be much more valuable, says Michael Cima, an MIT professor of materials science and engineering. He has developed the first implantable device that can do just that.

Mini monitor Grad student Christophoros Vassiliou ‘04, MEng ‘06 (right), holds the cancer monitoring device that Professor Michael Cima (left) developed with him and Grace Kim, PhD ‘08.

“What this does is basically take the lab and put it in the patient,” says Cima, who is also an investigator at the David H. Koch Institute for Integrative Cancer Research at MIT.

The device, which could be implanted at the time of a biopsy, would provide up-to-the-minute information about a tumor–whether it’s growing or shrinking, whether chemotherapy drugs have reached it, and whether it has metastasized or is about to do so. In a paper published in the journal Biosensors & Bioelectronics, Cima and his colleagues recently reported that their device successfully tracked for one month a chemical produced by human tumors growing in mice.

The cylindrical, five-­millimeter implant contains magnetic nanoparticles coated with antibodies specific to target molecules such as hormones produced by tumor cells. When target molecules enter the implant through a semipermeable membrane, they bind to the particles and cause them to clump together. Magnetic resonance imaging can detect the clumps–and track whether they’re getting bigger or smaller.

Implants that can test for pH levels, which reveal a tumor’s metabolism and its response to chemotherapy, could be commercially available in a few years, Cima says. These would be followed by devices that test for complex chemicals such as hormones and drugs.

Unlike biopsies, such technologies could alert doctors that the original tumor has started shedding cancer cells before those cells can form new tumors. “This is one of the tools we’re going to need if we’re going to turn cancer from a death sentence to a manageable disease,” Cima says.

Keep Reading

Most Popular

SpaceX Starship
SpaceX Starship

How SpaceX’s massive Starship rocket might unlock the solar system—and beyond

With the first orbital test launch of Starship on the horizon, scientists are dreaming about what it might make possible— from trips to Neptune to planetary defense.

a Chichuahua standing on a Great Dane
a Chichuahua standing on a Great Dane

DeepMind says its new language model can beat others 25 times its size

RETRO uses an external memory to look up passages of text on the fly, avoiding some of the costs of training a vast neural network

Conceptual illustration of a therapy session
Conceptual illustration of a therapy session

The therapists using AI to make therapy better

Researchers are learning more about how therapy works by examining the language therapists use with clients. It could lead to more people getting better, and staying better.

Photograph of Geothermal power plant located at Reykjanes peninsula in Iceland. Aerial view
Photograph of Geothermal power plant located at Reykjanes peninsula in Iceland. Aerial view

What it will take to unleash the potential of geothermal power

Four new pilot plants funded by the US infrastructure bill could help expand the range of the “forgotten renewable.”

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.